These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 31880895)

  • 1. New Look on Antifungal Activity of Silver Nanoparticles (AgNPs).
    Żarowska B; Koźlecki T; Piegza M; Jaros-Koźlecka K; Robak M
    Pol J Microbiol; 2019 Dec; 68(4):515-525. PubMed ID: 31880895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, characterization and evaluation of antimicrobial and cytotoxic activities of biogenic silver nanoparticles synthesized from Streptomyces xinghaiensis OF1 strain.
    Wypij M; Czarnecka J; Świecimska M; Dahm H; Rai M; Golinska P
    World J Microbiol Biotechnol; 2018 Jan; 34(2):23. PubMed ID: 29305718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silver nanoparticles induce reactive oxygen species-mediated cell cycle delay and synergistic cytotoxicity with 3-bromopyruvate in
    Lee B; Lee MJ; Yun SJ; Kim K; Choi IH; Park S
    Int J Nanomedicine; 2019; 14():4801-4816. PubMed ID: 31308659
    [No Abstract]   [Full Text] [Related]  

  • 4. Pleurotus sajor-caju can be used to synthesize silver nanoparticles with antifungal activity against Candida albicans.
    Musa SF; Yeat TS; Kamal LZM; Tabana YM; Ahmed MA; El Ouweini A; Lim V; Keong LC; Sandai D
    J Sci Food Agric; 2018 Feb; 98(3):1197-1207. PubMed ID: 28746729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiochemical properties of Trichoderma longibrachiatum DSMZ 16517-synthesized silver nanoparticles for the mitigation of halotolerant sulphate-reducing bacteria.
    Omran BA; Nassar HN; Younis SA; Fatthallah NA; Hamdy A; El-Shatoury EH; El-Gendy NS
    J Appl Microbiol; 2019 Jan; 126(1):138-154. PubMed ID: 30199141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial and cytotoxic activity of silver nanoparticles synthesized from two haloalkaliphilic actinobacterial strains alone and in combination with antibiotics.
    Wypij M; Świecimska M; Czarnecka J; Dahm H; Rai M; Golinska P
    J Appl Microbiol; 2018 Jun; 124(6):1411-1424. PubMed ID: 29427473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silver nanoparticles induced alterations in multiple cellular targets, which are critical for drug susceptibilities and pathogenicity in fungal pathogen (
    Radhakrishnan VS; Reddy Mudiam MK; Kumar M; Dwivedi SP; Singh SP; Prasad T
    Int J Nanomedicine; 2018; 13():2647-2663. PubMed ID: 29760548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzyme-mediated formulation of stable elliptical silver nanoparticles tested against clinical pathogens and MDR bacteria and development of antimicrobial surgical thread.
    Thapa R; Bhagat C; Shrestha P; Awal S; Dudhagara P
    Ann Clin Microbiol Antimicrob; 2017 May; 16(1):39. PubMed ID: 28511708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and antimicrobial activity of silver nanoparticles mycosynthesized by Aspergillus brasiliensis.
    Omran BA; Nassar HN; Fatthallah NA; Hamdy A; El-Shatoury EH; El-Gendy NS
    J Appl Microbiol; 2018 Aug; 125(2):370-382. PubMed ID: 29624805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial and Antifungal Properties of Silver Nanoparticles-Effect of a Surface-Stabilizing Agent.
    Gibała A; Żeliszewska P; Gosiewski T; Krawczyk A; Duraczyńska D; Szaleniec J; Szaleniec M; Oćwieja M
    Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrastructural analysis of Candida albicans when exposed to silver nanoparticles.
    Vazquez-Muñoz R; Avalos-Borja M; Castro-Longoria E
    PLoS One; 2014; 9(10):e108876. PubMed ID: 25290909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review on biosynthesis of silver nanoparticles and their biocidal properties.
    Siddiqi KS; Husen A; Rao RAK
    J Nanobiotechnology; 2018 Feb; 16(1):14. PubMed ID: 29452593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial activity of fluorescent Ag nanoparticles.
    Bera RK; Mandal SM; Raj CR
    Lett Appl Microbiol; 2014 Jun; 58(6):520-6. PubMed ID: 24460988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ZnO, TiO2 and Ag nanoparticles impact against some species of pathogenic bacteria and yeast.
    Mohammed AK; Salh KK; Ali FA
    Cell Mol Biol (Noisy-le-grand); 2021 Nov; 67(3):24-34. PubMed ID: 34933736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silver nanoparticles from Pilimelia columellifera subsp. pallida SL19 strain demonstrated antifungal activity against fungi causing superficial mycoses.
    Wypij M; Czarnecka J; Dahm H; Rai M; Golinska P
    J Basic Microbiol; 2017 Sep; 57(9):793-800. PubMed ID: 28670763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silver Nanoparticles with High Loading Capacity of Amphotericin B: Characterization, Bactericidal and Antifungal Effects.
    Leonhard V; Alasino RV; Munoz A; Beltramo DM
    Curr Drug Deliv; 2018; 15(6):850-859. PubMed ID: 28925873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Size and Shape-Dependent Antimicrobial Activities of Silver and Gold Nanoparticles: A Model Study as Potential Fungicides.
    Osonga FJ; Akgul A; Yazgan I; Akgul A; Eshun GB; Sakhaee L; Sadik OA
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32527041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellulose nanowhiskers decorated with silver nanoparticles as an additive to antibacterial polymers membranes fabricated by electrospinning.
    Spagnol C; Fragal EH; Pereira AGB; Nakamura CV; Muniz EC; Follmann HDM; Silva R; Rubira AF
    J Colloid Interface Sci; 2018 Dec; 531():705-715. PubMed ID: 30077948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal activity of silver nanoparticles obtained by green synthesis.
    Mallmann EJ; Cunha FA; Castro BN; Maciel AM; Menezes EA; Fechine PB
    Rev Inst Med Trop Sao Paulo; 2015; 57(2):165-7. PubMed ID: 25923897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of
    Lara HH; Ixtepan-Turrent L; Jose Yacaman M; Lopez-Ribot J
    ACS Appl Mater Interfaces; 2020 May; 12(19):21183-21191. PubMed ID: 31944650
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.